Meeting of the Presidential Advisory Council on HIV/AIDS, 55514-55515 [E8-22580]
Download as PDF
<![CDATA[
55514
Federal Register / Vol. 73, No. 187 / Thursday, September 25, 2008 / Notices
to Mr. Robert E. Feldman, Executive
Secretary of the Corporation, at (202)
898–7122.
Dated: September 19, 2008.
Federal Deposit Insurance Corporation.
Valerie J. Best,
Assistant Executive Secretary.
[FR Doc. E8–22501 Filed 9–24–08; 8:45 am]
BILLING CODE 6714–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Chronic Fatigue
Syndrome Advisory Committee
Department of Health and
Human Services, Office of the Secretary,
Office of Public Health and Science.
ACTION: Notice.
mstockstill on PROD1PC66 with NOTICES
AGENCY:
SUMMARY: As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Services is hereby giving notice that the
Chronic Fatigue Syndrome Advisory
Committee (CFSAC) will hold a
meeting. The meeting will be open to
the public.
DATES: The meeting will be held on
Tuesday, October 28, 2008, and
Wednesday, October 29, 2008. The
meeting will be held from 9 a.m. to
approximately 5 p.m. on both days.
ADDRESSES: Department of Health and
Human Services; Room 800 Hubert H.
Humphrey Building; 200 Independence
Avenue, SW.; Washington, DC 20201
FOR FURTHER INFORMATION CONTACT: Dr.
Anand K. Parekh, Executive Secretary,
Chronic Fatigue Syndrome Advisory
Committee; Department of Health and
Human Services; 200 Independence
Avenue, SW., Room 727H; Washington,
DC 20201; (202) 401–7605 or Olga
Nelson, Committee Management Officer,
Office of Public Health and Science;
U.S. Department of Health and Human
Services; 200 Independence Avenue,
SW., Room 714B; Washington, DC
20201; (202) 690–5205.
SUPPLEMENTARY INFORMATION: CFSAC
was established on September 5, 2002.
The Committee was established to
advise, consult with, and make
recommendations to the Secretary,
through the Assistant Secretary for
Health, on a broad range of topics
including (1) the current state of
knowledge and research about the
epidemiology and risk factors relating to
chronic fatigue syndrome, and
identifying potential opportunities in
these areas; (2) current and proposed
diagnosis and treatment methods for
chronic fatigue syndrome; and (3)
development and implementation of
VerDate Aug<31>2005
17:50 Sep 24, 2008
Jkt 214001
programs to inform the public, health
care professionals, and the biomedical,
academic, and research communities
about chronic fatigue syndrome
advances.
The agenda for this meeting is being
developed. The agenda will be posted
on the CFSAC Web site, https://
www.hhs.gov/advcomcfs, when it is
finalized.
Public attendance at the meeting is
strongly encouraged. Individuals must
provide a photo ID for entry into the
building where the meeting is
scheduled to be held. Individuals who
plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
designated contact person. Members of
the public will have the opportunity to
provide comments at the meeting. The
committee is very interested to hear
about experiences that individuals with
chronic fatigue syndrome have had
interfacing with the medical
community. In addition, the committee
welcomes specific comments on issues
surrounding chronic fatigue syndrome
research, provider education, and
quality of life. Individuals who wish to
address the Committee during the
public comment session must preregister by October 23, 2008. Any
individual who wishes to participate in
the public comment session should call
the telephone number listed in the
contact information to register. Public
comment will be limited to five minutes
per speaker. Members of the public who
wish to have printed material
distributed to CFSAC members for
discuss should submit, at a minimum,
one copy of the material to the OPHS
Committee Management Officer prior to
close of business on October 23, 2008.
Contact information for the OPHS
Committee Management Officer is listed
above.
Dated: September 19, 2008.
Anand K. Parekh,
Executive Secretary, Chronic Fatigue
Syndrome Advisory Committee.
[FR Doc. E8–22577 Filed 9–24–08; 8:45 am]
BILLING CODE 4150–42–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Presidential Advisory
Council on HIV/AIDS
Department of Health and
Human Services, Office of the Secretary,
Office of Public Health and Science.
AGENCY:
ACTION:
PO 00000
Notice.
Frm 00019
Fmt 4703
Sfmt 4703
SUMMARY: As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Services (DHHS) is hereby giving notice
that the Presidential Advisory Council
on HIV/AIDS (PACHA) will hold a
meeting. The meeting will be open to
the public.
DATES: The meeting will be held
Tuesday, October 21, 2008 and
Wednesday, October 22, 2008. The
meeting will be held from 9 a.m. to
approximately 4 p.m. on October 21,
and from 10 a.m. to approximately 4
p.m. on October 22.
ADDRESSES: Department of Health and
Human Services, Room 800, Hubert H.
Humphrey Building, 200 Independence
Avenue, SW., Washington, DC 20201.
FOR FURTHER INFORMATION CONTACT: Ms.
Nancy Barnes, Committee Manager,
Presidential Advisory Council on HIV/
AIDS, Department of Health and Human
Services, 200 Independence Avenue,
SW., Room 727G, Hubert H. Humphrey
Building, Washington, DC 20201; (202)
205–2311. More detailed information
about PACHA can be obtained by
accessing the Council’s Web site at
https://www.pacha.gov.
SUPPLEMENTARY INFORMATION: PACHA
was established by Executive Order
12963, dated June 14, 1995, as amended
by Executive Order 13009, dated June
14, 1996. The Council was established
to provide advice, information, and
recommendations to the Secretary
regarding programs and policies
intended to (a) Promote effective
prevention of HIV disease, (b) advance
research on HIV and AIDS, and (c)
promote quality services to persons
living with HIV disease and AIDS.
PACHA was established to serve solely
as an advisory body to the Secretary of
Health and Human Services. The
Council is composed of not more than
21 members. Council membership is
selected by the Secretary from
individuals who are considered
authorities with particular expertise in,
or knowledge of, matters concerning
HIV and AIDS.
The agenda for this Council meeting
is being developed. The meeting agenda
will be posted on the Council’s Web site
when it is drafted.
Public attendance at the meeting is
limited to space available. Individuals
must provide a photo ID for entry into
the building. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the designated contact person.
Pre-registration for public attendance is
advisable and can be accomplished
E:\FR\FM\25SEN1.SGM
25SEN1
Federal Register / Vol. 73, No. 187 / Thursday, September 25, 2008 / Notices
online by accessing the PACHA Web
site, https://www.pacha.gov.
Members of the public will have the
opportunity to provide comments at the
meeting. Pre-registration is required for
public comment. Any individual who
wishes to participate in the public
comment session must register online at
https://www.pacha.gov; registration for
public comment will not be accepted by
telephone. Public comment will be
limited to three minutes per speaker.
Any members of the public who wish to
have printed material distributed to
PACHA members for discussion at the
meeting should submit, at a minimum,
one copy of the materials to the
Committee Manager, PACHA no later
than close of business on October 14,
2008. Contact information for the
PACHA Committee Manager is listed
above.
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Dated: September 19, 2008.
Mary (Marty) McGeein,
Executive Director, Presidential Advisory
Council on HIV/AIDS.
[FR Doc. E8–22580 Filed 9–24–08; 8:45 am]
Background and Brief Description
Tobacco use remains the leading
preventable cause of death in the United
States despite the availability of
evidence-based treatments for tobacco
dependence, which include counseling
and FDA-approved pharmacotherapies.
To increase both the use of treatment by
smokers attempting to quit and the
number of smokers who quit
successfully, the Guide to Community
Preventive Services recommends
reducing the out-of-pocket cost of
effective tobacco-dependence
treatments, and the Public Health
Service (PHS) Clinical Practice
Guideline supports expanded insurance
coverage for tobacco-dependence
treatment.
Medicaid recipients have
approximately 50% greater smoking
prevalence than the overall U.S. adult
population, and they are
disproportionately affected by tobaccorelated disease and disability. In 2000,
approximately 32 million low-income
persons in the United States received
their health insurance coverage through
federally funded State Medicaid
programs, and approximately 11.5
million (36%) of these persons smoked.
Substantial action to improve coverage
of tobacco-dependence treatments
through Medicaid will be needed if the
United States is to achieve the 2010
National Health Objective of 12%
smoking prevalence among adults.
The amount and type of coverage for
tobacco-dependence treatment offered
by Medicaid has been collected for
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60-Day–08–0691]
mstockstill on PROD1PC66 with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 or send
comments to Maryam Daneshvar, CDC
Acting Reports Clearance Officer, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
VerDate Aug<31>2005
17:50 Sep 24, 2008
Jkt 214001
Proposed Project
State Medicaid Tobacco Coverage
Survey (OMB No. 0920–0691)—
Reinstatement—National Center for
Chronic Disease Prevention and Control
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
PO 00000
Frm 00020
Fmt 4703
Sfmt 4703
55515
1998, 2000, 2001, 2002, 2003, 2005,
2006, and 2007. Surveys have been
funded by the Robert Wood Johnson
Foundation (RWJF) (1998, 2000–2003)
and the Centers for Disease Control and
Prevention (CDC) (2005–2007) (OMB
No. 0920–0691, expiration date 8/31/
2008). The most recent analysis of these
information collections demonstrated
that in 2006, 39 states provided
coverage for some FDA-approved
medications for the general Medicaid
population; however, only 17 states
provided some form of coverage for
counseling and only seven states
covered all FDA-approved medications
and at least one form of counseling for
all enrollees. Some progress has been
made in that the number of states
offering no benefits decreased from 15
in 2002 to eight in 2006.
CDC plans to request reinstatement of
OMB approval to collect similar
information about Medicaid coverage of
tobacco-dependence treatments during
the years 2008–2010. Respondents will
be Medicaid directors in all 50 states
and the District of Columbia. To
minimize burden, each respondent will
receive an electronic copy of the survey
pre-filled with the previous year’s
results. Respondents will only be asked
to record changes that occurred since
the time of the previous submission. In
addition, respondents will be asked to
answer new questions pertaining to the
recommendations made in the updated
PHS clinical practice guideline issued
in May of 2008 regarding coverage for
combination therapies, smokeless
tobacco use, and their familiarity with
and use of the 2000 PHS guideline. The
minor changes to be incorporated in the
revised survey instrument are not
expected to have a significant impact on
the overall burden estimate. As in
previous years, each respondent will
also attach a copy of the state’s
Medicaid coverage plan to their
completed survey, in order to assist the
research team with the interpretation of
responses.
The information to be collected will
allow CDC to continue monitoring
compliance with the most recent PHS
recommendations and the progress of
State Medicaid Programs toward the
2010 National Health Objectives and
Healthy People 2010 goals.
There are no costs to respondents
except the time to complete the survey.
E:\FR\FM\25SEN1.SGM
25SEN1
]]>Agencies
[Federal Register Volume 73, Number 187 (Thursday, September 25, 2008)]
[Notices]
[Pages 55514-55515]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-22580]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Presidential Advisory Council on HIV/AIDS
AGENCY: Department of Health and Human Services, Office of the
Secretary, Office of Public Health and Science.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S.
Department of Health and Human Services (DHHS) is hereby giving notice
that the Presidential Advisory Council on HIV/AIDS (PACHA) will hold a
meeting. The meeting will be open to the public.
DATES: The meeting will be held Tuesday, October 21, 2008 and
Wednesday, October 22, 2008. The meeting will be held from 9 a.m. to
approximately 4 p.m. on October 21, and from 10 a.m. to approximately 4
p.m. on October 22.
ADDRESSES: Department of Health and Human Services, Room 800, Hubert H.
Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201.
FOR FURTHER INFORMATION CONTACT: Ms. Nancy Barnes, Committee Manager,
Presidential Advisory Council on HIV/AIDS, Department of Health and
Human Services, 200 Independence Avenue, SW., Room 727G, Hubert H.
Humphrey Building, Washington, DC 20201; (202) 205-2311. More detailed
information about PACHA can be obtained by accessing the Council's Web
site at https://www.pacha.gov.
SUPPLEMENTARY INFORMATION: PACHA was established by Executive Order
12963, dated June 14, 1995, as amended by Executive Order 13009, dated
June 14, 1996. The Council was established to provide advice,
information, and recommendations to the Secretary regarding programs
and policies intended to (a) Promote effective prevention of HIV
disease, (b) advance research on HIV and AIDS, and (c) promote quality
services to persons living with HIV disease and AIDS. PACHA was
established to serve solely as an advisory body to the Secretary of
Health and Human Services. The Council is composed of not more than 21
members. Council membership is selected by the Secretary from
individuals who are considered authorities with particular expertise
in, or knowledge of, matters concerning HIV and AIDS.
The agenda for this Council meeting is being developed. The meeting
agenda will be posted on the Council's Web site when it is drafted.
Public attendance at the meeting is limited to space available.
Individuals must provide a photo ID for entry into the building.
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations, should
notify the designated contact person. Pre-registration for public
attendance is advisable and can be accomplished
[[Page 55515]]
online by accessing the PACHA Web site, https://www.pacha.gov.
Members of the public will have the opportunity to provide comments
at the meeting. Pre-registration is required for public comment. Any
individual who wishes to participate in the public comment session must
register online at https://www.pacha.gov; registration for public
comment will not be accepted by telephone. Public comment will be
limited to three minutes per speaker. Any members of the public who
wish to have printed material distributed to PACHA members for
discussion at the meeting should submit, at a minimum, one copy of the
materials to the Committee Manager, PACHA no later than close of
business on October 14, 2008. Contact information for the PACHA
Committee Manager is listed above.
Dated: September 19, 2008.
Mary (Marty) McGeein,
Executive Director, Presidential Advisory Council on HIV/AIDS.
[FR Doc. E8-22580 Filed 9-24-08; 8:45 am]
BILLING CODE 4150-28-P
